Table 1. Baseline Characteristics; n=331*.
CHARACTERISTIC** | |
---|---|
| |
Median age, in years (range) | 72 (65, 90) |
| |
Study arm | |
cyclophosphamide/methotrexate/5-fluorouracil or doxorubicin/cyclophosphamide | 171 (52) |
capecitabine | 160 (48) |
| |
Marital status | |
Married | 179 (55) |
Not married | 146 (45) |
| |
Cohabitation | |
With at least one person | 210 (65) |
Alone | 115 (35) |
| |
Size of support group | |
0-10 people | 145 (46) |
11-25 people | 110 (35) |
26+ people | 58 (19) |
| |
Emotional/informational support score, median (range) | 94 (3.1, 100) |
| |
Tangible support score, median (range) | 94 (0, 100) |
| |
Social interaction support score, median (range) | 96 (0, 100) |
| |
Affectionate support score, median (range) | 100 (8.3, 100) |
Numbers in parentheses refer to percentages unless otherwise specified.
Missing response data account for a sum of less than 331 at times.